Applicant, as named in the Orange Book

Exeltis Usa Inc

Next listed expiry: Slynd on 28 Jun 2031. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Slynd NDA 211367 drospirenone	drospirenone	28 Jun 2031 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Tyblume NDA 209405 ethinyl estradiol; levonorgestrel	ethinyl estradiol; levonorgestrel	open now no listed protection	no listed protection